Document:

EX-10.7.B

 

EXHIBIT 10.7(b)

AMENDMENT NO. 1 TO

EXECUTIVE EMPLOYMENT AGREEMENT

          THIS AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is made as of this
3rd day of April, 2006, by and between Mylan Laboratories Inc., a Pennsylvania
corporation (the “Company”), and Louis J. DeBone (“Executive”).

          WHEREAS, the Company and Executive are party to that certain Executive Employment Agreement
dated as of July 1, 2004 (the “Agreement”);

          WHEREAS, the Executive has notified the Company that he plans to retire from the Company
effective as of September 1, 2006;

          WHEREAS, in connection with Executive’s retirement, the Company and Executive desire to amend
the Agreement, effective as of April 1, 2006, as permitted by Section 15 of the Agreement, upon the
terms and conditions set forth herein;

          NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

	 	1.	 	Section 8(a) is hereby amended to restate the fourth sentence of such subsection in
its entirety as follows:

“Except as provided in Section 8(c) and 8(d), the Company shall have no liability to Executive
under this subsection other than that the Company shall pay Executive’s wages and benefits
through the effective date of Executive’s resignation.”

	 	2.	 	Section 8(b) of the Agreement is hereby deleted in its entirety and replaced with the
following:

“Termination for Cause. The Company may terminate the Executive’s employment for Cause.
“Cause” shall mean: (i) the Executive’s willful and substantial misconduct with respect to the
Company’s business or affairs; (ii) the Executive’s gross neglect of duties, or (iii) the
Executive’s conviction of any felony, which, in the case of clauses (i) and (ii) of this
definition, has not been cured within 30 days after a written demand for substantial
performance is delivered to the Executive by the Board, which demand specifically identifies
the manner in which the Board believes that the Executive has engaged in conduct that
constitutes Cause under this Agreement. For purposes of clauses (i) and (ii) of this
definition, (x) no act, or failure to act, on the Executive’s part shall be deemed “willful”
unless done, or omitted to be done, by the Executive not in good faith and without reasonable
belief that the Executive’s act, or failure to act, was in the best interest of the Company (y)
no termination shall be treated as a termination for “Cause” unless, after the Executive and
his counsel have had an opportunity to be heard by the Board, the Board reaches a finding
through a

 

 

vote of at least three-quarters of the entire Board that Cause exists, and (z) in the event of
a dispute concerning the existence of “Cause,” any claim by the Executive that “Cause” does not
exist shall be presumed correct unless the Company establishes by clear and convincing evidence
that Cause exists.”

	 	3.	 	The following proviso is hereby added to the end of the second sentence of Section
8(c) of the Agreement:

“provided, that such lump sum payment shall be reduced by any disability benefits that the
Executive is entitled to pursuant to plans or arrangements of the Company.”

	 	4.	 	Section 8(d) is hereby amended and restated in its entirety to read as follows:

“Extension or Renewal; Retirement. The Term of Employment may be extended or renewed upon
mutual agreement of Executive and the Company. If (i) the Term of Employment is not extended
or renewed on terms mutually acceptable to Executive and the Company and if this Agreement has
not already been terminated for reasons stated in Section 8(a), (b) or (c) of this Agreement,
or (ii) if Executive retires from the Company on or after September 1, 2006, Executive shall be
paid, within 30 days of separation from the Company, a lump sum equal to his then-current
Minimum Base Salary plus the Prior Bonus. In addition, Executive’s health insurance benefits
shall be continued for 12 months at the Company’s cost; provided, however, that in the case of
health insurance continuation, the Company’s obligation to provide health insurance benefits
shall end at such time as Executive, at his option, voluntarily obtains health insurance
benefits through another employer or otherwise in connection with rendering services for a
third party. Executive, however, will continue to be bound by all provisions of this Agreement
that survive termination of employment.”

	 	5.	 	The following proviso is hereby added to the end of the final sentence of Section
8(g) of the Agreement:

“provided, however, that such consideration, compensation, and benefits shall be reduced by any
death benefits that the Executive’s estate or beneficiaries are entitled to pursuant to plans
or arrangements of the Company.”

	 	6.	 	The following is hereby added as Section 8(h) of the Agreement:

“Section 409A. Notwithstanding anything to the contrary in this Agreement, the payment of
consideration, compensation, and benefits pursuant to this Section 8 shall be interpreted and
administered in manner intended to avoid the imposition of additional taxes under Section 409A
of the Internal Revenue Code.”

	 	7.	 	The parties acknowledge and agree that this Amendment is an integral part of the
Agreement. Notwithstanding any provision of the Agreement to the contrary, in

2

 

	 	 	 	the event of any conflict between this Amendment and the Agreement or any part of either of
them, the terms of this Amendment shall control.
	 
	 	8.	 	Except as expressly set forth herein, the terms and conditions of the Agreement are
and shall remain in full force and effect.
	 
	 	9.	 	The Agreement, as amended by this Amendment, sets forth the entire understanding of
the parties with respect to the subject matter thereof and hereof.
	 
	 	10.	 	This Amendment shall be governed by, interpreted under and construed in accordance
with the laws of the Commonwealth of Pennsylvania.
	 
	 	11.	 	This Amendment may be executed in any number of counterparts, each of which shall be
an original and all of which shall constitute one and the same document.

          IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the day and year
first above written.

	 	 	 	 	 	 	 
	 	 	MYLAN LABORATORIES INC.
	 
	 	 	 	 	 	 
	 

	 	By:
	  /s/ Robert J. Coury	 	 
	 

	 	 	 	 	 
	 	 	Name: Robert J. Coury
	 	 	Title: Vice Chairman and CEO

	 
	 	 	 	 	 	 
	 	 	  /s/ Louis J. DeBone
	 	 	 	 	 
	 	 	Louis J. DeBone

3EX-10.8.B

 

EXHIBIT 10.8(b)

AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT

          THIS AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) by and between Mylan
Laboratories Inc., a Pennsylvania corporation (the “Company”) and John P. O’Donnell (the
“Executive”), is made as of April 3, 2006.

          WHEREAS, the Company and the Executive are parties to that certain Executive Employment
Agreement dated as of July 1, 2004 (the “Agreement”);

          WHEREAS, the Company and the Executive wish to amend the Agreement, effective as of April 1,
2006, as set forth below;

          NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

	 	1.	 	The following proviso is hereby added to the end of the second sentence of Section
8(c) of the Agreement:

“provided, that, such lump sum payment shall be reduced by any disability benefits that the
Executive is entitled to pursuant to plans or arrangements of the Company.”

	 	2.	 	The following proviso is hereby added to the end of the final sentence of Section
8(g) of the Agreement:

“provided, however, that such consideration, compensation, and benefits shall be reduced by any
death benefits that the Executive’s estate or beneficiaries are entitled to pursuant to plans
or arrangements of the Company.”

	 	3.	 	The following is hereby added as Section 8(h) of the Agreement:

“Section 409A. Notwithstanding anything to the contrary in this Agreement, the payment of
consideration, compensation, and benefits pursuant to this Section 8 shall be interpreted and
administered in manner intended to avoid the imposition of additional taxes under Section 409A
of the Internal Revenue Code.”

	 	4.	 	This Amendment shall be governed by, interpreted under and construed in accordance
with the laws of the Commonwealth of Pennsylvania.
	 
	 	5.	 	This Amendment may be executed in counterparts, each of which shall be an original
and all of which shall constitute the same document.
	 
	 	6.	 	Except as modified by this Amendment, the Agreement is hereby confirmed in all
respects.

 

 

          IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date and the
year first written above.

	 	 	 	 	 	 	 
	 	 	MYLAN LABORATORIES INC.
	 
	 	 	 	 	 	 
	 

	 	By:
	  /s/ Robert J. Coury	 	 
	 

	 	 	 	 	 
	 	 	Name: Robert J. Coury
	 	 	Title: Vice Chairman and CEO
	 
	 	 	 	 	 	 
	 	 	EXECUTIVE
	 
	 	 	 	 	 	 
	 	 	  /s/ John P. O’Donnell
	 	 	 	 	 
	 	 	John P. O’Donnell

2EX-10.9.B

 

EXHIBIT 10.9(b)

AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT

          THIS AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) by and between Mylan
Laboratories Inc., a Pennsylvania corporation (the “Company”) and Stuart A. Williams (the
“Executive”), is made as of April 3, 2006.

          WHEREAS, the Company and the Executive are parties to that certain Executive Employment
Agreement dated as of July 1, 2004 (the “Agreement”);

          WHEREAS, the Company and the Executive wish to amend and extend the Agreement, effective as of
April 1, 2006, as set forth below;

          NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

	 	1.	 	Section 2 of the Agreement is hereby deleted and replaced in its entirety to read as
follows:

“Effective Date; Termination of Employment. This Agreement shall commence and be effective as
of the date hereof and shall remain in effect, unless earlier terminated or extended or
renewed, as provided in Section 8 of this Agreement, through March 31, 2007.”

	 	2.	 	The following proviso is hereby added to the end of the final sentence of Section
8(d) of the Agreement:

“provided, however, that such consideration, compensation, and benefits shall be reduced by any
benefits that the Executive or the Executive’s estate or beneficiaries are entitled to pursuant
to plans or arrangements of the Company.”

	 	3.	 	The following is hereby added as Section 8(h) of the Agreement:

“Section 409A. Notwithstanding anything to the contrary in this Agreement, the payment of
consideration, compensation, and benefits pursuant to this Section 8 shall be interpreted and
administered in manner intended to avoid the imposition of additional taxes under Section 409A
of the Internal Revenue Code.”

	 	4.	 	This Amendment shall be governed by, interpreted under and construed in accordance
with the laws of the Commonwealth of Pennsylvania.
	 
	 	5.	 	This Amendment may be executed in counterparts, each of which shall be an original
and all of which shall constitute the same document.

 

 

	 	6.	 	Except as modified by this Amendment, the Agreement is hereby confirmed in all
respects.

          IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date and the
year first written above.

	 	 	 	 	 	 	 
	 	 	MYLAN LABORATORIES INC.
	 
	 	 	 	 	 	 
	 

	 	By:
	  /s/ Robert J. Coury	 	 
	 

	 	 	 	 	 
	 	 	Name: Robert J. Coury
	 	 	Title: Vice Chairman and CEO
	 
	 	 	 	 	 	 
	 	 	EXECUTIVE
	 
	 	 	 	 	 	 
	 	 	  /s/ Stuart A. Williams
	 	 	 	 	 
	 	 	Stuart A. Williams

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]